Radical scavenging and NO-releasing properties of selected b-adrenoreceptor antagonists

Free Radical Research

Volumn 40, Issue 7, 2006, Pages 741-752

  Szajerski, Piotr ^a   Zielonka, Jacek ^a   Sikora, Adam ^a   Adamus, Jan ^a   Marcinek, Andrzej ^a   Gebicki, Jerzy ^a   Kozlovski, Valery I ^b   Drelicharz, Łukasz ^b   Chłopicki, Stefan ^b  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Carvedilol; Nebivolol; NO release; Radical scavenging

Indexed keywords

BENZOPYRAN DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; CARVEDILOL; EPOXIDE; ETHANOLAMINE DERIVATIVE; METHYLAMINE; NEBIVOLOL; NITRIC OXIDE; PROPANOLAMINE DERIVATIVE; PROPYLENE OXIDE; SCAVENGER;

ANIMAL; ARTICLE; CHEMISTRY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DRUG EFFECT; FEMALE; GUINEA PIG; IN VITRO STUDY; MALE; METABOLISM; PHYSIOLOGY; PULSE RADIOLYSIS; VASCULAR ENDOTHELIUM; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BENZOPYRANS; CARBAZOLES; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; EPOXY COMPOUNDS; ETHANOLAMINES; FEMALE; FREE RADICAL SCAVENGERS; GUINEA PIGS; MALE; METHYLAMINES; NITRIC OXIDE; PROPANOLAMINES; PULSE RADIOLYSIS; VASODILATION;

EID: 37349088295     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760600690329     Document Type: Article

References (66)

1. Altwegg LA, d'Uscio LV, Barandier C, Cosentino F, Yang Z, Luscher TF. Nebivolol induces NO-mediated relaxations of rat small mesenteric but not of large elastic arteries. J Cardiovasc Pharmacol 2000;36:316-320 (Pubitemid 30660461)
2. Cockcroft JR, Chowienczyk PJ, Brett SE, Chen CP, Dupont AG, Van Nueten L, Wooding SJ, Ritter JM. Nebivolol vasodilates human forearm vasculature: Evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther 1995;274:1067-1071
3. Parenti A, Filippi S, Amerini S, Granger HJ, Fazzini A, Ledda F. Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol. J Pharmacol Exp Ther 2000; 292:698-703 (Pubitemid 30067434)
4. Chlopicki S, Kozlovski VI, Gryglewski RJ. NO-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by beta-adrenoceptors or by 5 HT1A-receptors. J Physiol Pharmacol 2002;53:615-624 (Pubitemid 36014806)
5. Dawes M, Brett SE, Chowienczyk PJ, Mant TG, Ritter JM. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension. Br J Clin Pharmacol 1999;48:460-463 (Pubitemid 29417735)
6. Ritter JM. Nebivolol: Endothelium-mediated vasodilating effect. J Cardiovasc Pharmacol 2001;38(Suppl 3):S13-S16 (Pubitemid 34026334)
7. Tzemos N, Lim PO, MacDonald TM. Nebivolol reverses endothelial dysfunction in essential hypertension: A randomized, double-blind, crossover study. Circulation 2001;104:511-514 (Pubitemid 32738117)
8. Lekakis JP, Protogerou A, Papamichael C, Vamvakou G, Iconomidis I, Fici F, Mavrikakis M. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease. Cardiovasc Drugs Ther 2005; Sep 20: [Epub ahead of print]
9. Cosentino F, Bonetti S, Rehorik R, Eto M, Werner-Felmayer G, Volpe M, Luscher TF. Nitric-oxide-mediated relaxations in salt-induced hypertension: Effect of chronic beta1-selective receptor blockade. J Hypertens 2002;20:421-428 (Pubitemid 34913741)
10. Matsuda Y, Akita H, Terashima M, Shiga N, Kanazawa K, Yokoyama M. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease. Am Heart J 2000;140:753-759
11. Kalinowski L, Dobrucki LW, Szczepanska-Konkel M, Jankowski M, Martyniec L, Angielski S, Malinski T. Thirdgeneration beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: A novel mechanism for antihypertensive action. Circulation 2003;107:2747-2752 (Pubitemid 36667251)
12. Troost R, Schwedhelm E, Rojczyk S, Tsikas D, Frolich JC. Nebivolol decreases systemic oxidative stress in healthy volunteers. Br J Clin Pharmacol 2000;50:377-379
13. Cominacini L, Fratta PA, Garbin U, Nava C, Davoli A, Criscuoli M, Crea A, Sawamura T, Lo CV. Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation. J Am Coll Cardiol 2003;42:1838-1844 (Pubitemid 37433667)
14. de Groot AA, Mathy MJ, van Zwieten PA, Peters SL. Antioxidant activity of nebivolol in the rat aorta. J Cardiovasc Pharmacol 2004;43:148-153 (Pubitemid 38032077)
15. Nakamura K, Kusano K, Nakamura Y, Kakishita M, Ohta K, Nagase S, Yamamoto M, Miyaji K, Saito H, Morita H, Emori T, Matsubara H, Toyokuni S, Ohe T. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 2002;105:2867-2871 (Pubitemid 34666100)
16. Zhang S, Sun Z, Liu L, Hasichaonu. Carvedilol attenuates CPB-induced apoptosis in dog heart: Regulation of Fas/FasL and caspase-3 pathway. Chin Med J (Engl) 2003; 116:761-766 (Pubitemid 36701866)
17. Janssen PM, Zeitz O, Hasenfuss G. Transient and sustained impacts of hydroxyl radicals on sarcoplasmic reticulum function: Protective effects of nebivolol. Eur J Pharmacol 1999;366:223-232 (Pubitemid 29080786)
18. Janssen PM, ZeitzO, Rahman A. Protective role of nebivolol in hydroxyl radical induced injury. J Cardiovasc Pharmacol 2001;38(Suppl 3):S17-S23
19. Flesch M, Maack C, Cremers B, Bäumer AT, Südkamp M, Böhm M. Effect of ß-blockers on free radical-induced cardiac contractile dysfunction. Circulation 1999;100:346-353 (Pubitemid 29362403)
20. Miura T, Muraoka S, Ogiso T. Protective effects of b-blockers against 2,20-azobis(2-amidinopropane)-dihydrochlorideinduced damage. Chem Biol Inter 1995;97:25-35
21. Lopez BL, Christopher TA, Yue TL, Ruffolo R, Feuerstein GZ, Ma XL. Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction. Pharmacol 1995;51:165-173
22. ChristopherTA, Lopez BL,Yue TL,Feuerstein GZ, Ruffolo Jr, RR, Ma XL. Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion. J Pharmacol Exp Ther 1995;273:64-71
23. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko K, Davis LL, Feuerstein GZ. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992;263:92-98
24. Yue TL, McKenna PJ, Ruffolo RP, Feuerstein GZ. Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils. Eur J Pharmacol 1992;214:277-280
25. Aruoma OI, Smith C, Cecchini R, Evans PJ, Halliwell B. Free radical scavenging and inhibition of lipid peroxidation by betablockers and by agents that interfere with calcium metabolism. A physiologically-significant process? Biochem Pharmacol 1991;42:735-743
26. Lysko PG,Webb CL, Gu JL, Ohlstein EH, Ruffolo Jr, RR, Yue TL. A comparison of carvedilol and metoprolol antioxidant activities in vitro. J Cariovasc Pharmacol 2000;36:277-281 (Pubitemid 30659851)
27. Tadolini B, Franconi F. Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism. Free Rad Res 1998;29:377-387 (Pubitemid 29047995)
28. Asbrink S, Zickert A, Bratt J, Gyllenhammar H, Palmblad J. No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions. Biochem Pharmacol 2000;59:1007-1013 (Pubitemid 30110817)
29. Mollnau H, Schulz E, Daiber A, Baldus S, Oelze M, August M, Wendt M, Walter U, Geiger C, Agrawal R, Kleschyov AL, Meinertz T, Munzel T. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler Thromb Vasc Biol 2003;23:615-621 (Pubitemid 36438074)
30. Noguchi N, Nishino K, Niki E. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation. Biochem Pharmacol 2000;59:1069-1076 (Pubitemid 30110499)
31. Yue TL, McKenna PJ, Gu JL, Cheng HY, Ruffolo Jr, RR, Feuerstein GZ. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells. Hypertens 1993;22:922-928 (Pubitemid 23358101)
32. Feurestein GZ, Yue TL. A potent antioxidant, SB209995, inhibits oxygen-radical-mediated lipid peroxidation and cytotoxicity. Pharmacol 1994;48:385-391
33. Yue TL, McKenna PJ, Lysko PG, Ruffolo Jr, RR, Feuerstein GZ. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper. Atheroscler 1992;97:209-216
34. Oettl K, Greilberger J, Zangger K, Haslinger E, Reibnegger G, Juergens G. Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity. Biochem Pharmacol 2001;62:241-248 (Pubitemid 32522945)
35. Gryglewski RJ,UraczW, Swies J,Chlopicki S,Marcinkiewicz E, Lomnicka M, Madej J. Comparison of endothelial pleiotropic actions of angiotensin converting enzyme inhibitors and statins. Ann N YAcad Sci 2001;947:229-245
36. Jakubowski A, Chlopicki S, Olszanecki R, Jawien J, Lomnicka M, Dupin JP, Gryglewski RJ. Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart. Prostaglandins Leukot Essent Fatty Acids 2005;72:139-145 (Pubitemid 40051231)
37. Schuler RH, Patterson LK, Janata E. Yield for the scavenging of hydroxyl radicals in the radiolysis of nitrous oxide-saturated aqueous solutions. J Phys Chem 1980;84:2088-2089
38. Karolczak S, Hodyr K, ?ubis R, Kroh J. Pulse radiolysis system based on ELU-6E linac. J Radioanal Nucl Chem 1986;101:177-188
39. Karolczak S, Hodyr K, Po?owiń ski M. Pulse radiolysis system based on ELU-6e linac-II. Development and upgrading the system. Radiat Phys Chem 1992;39:1-5
40. Buxton GV, Greenstock CL, Helman WP, Ross AB. Critical review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals in aqueous solution. J Phys Chem Ref Data 1988;17:513-886
41. Neta P, Huie RE, Ross AB. Rate constants for reactions of inorganic radicals in aqueous solutions. J Phys Chem Ref Data 1988;17:1027-1284
42. Wardman P. Reduction potentials of one-electron couples involving free radicals in aqueous solution. J Phys Chem Ref Data 1989;18:1637-1755
43. Shen X, Lind J, Eriksen TE, Merenyi G. Reactivity of the CCl3OOz radical. Evidence for a first-order transformation. J Phys Chem 1989;93:553-557
44. Neta P, Huie RE, Mosseri S, Shastri LV, Mittal JP, Maruthamuthu P, Steenken S. Rate constants for reduction of substituted methylperoxyl radicals by ascorbate ions and N, N, N0, N0-teramethyl-p-phenylenediamine. J Phys Chem 1989;93:4099-4104
45. Becke AD. Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 1993;98:5648-5652
46. Lee C, Yang W, Parr RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 1988;37:785-789
47. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchain HP, Cross JB, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenki A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian 03 Rev B 01. Pittsburgh: Gaussian Inc. 2003
48. Chlopicki S, Lomnicka M, Gryglewski RJ. Reversal of the postischaemic suppression of coronary function in perfused guinea pig heart by ischaemic preconditioning. J Physiol Pharmacol 1999;50:605-615 (Pubitemid 30022139)
49. Ge?bicki J, Sysa-Je?drzejowska A, Adamus J, Woźniacka A, Rybak M, Zielonka J. 1-Methylnicotinamide: A potent antiinflammatory agent of vitamin origin. Pol J Pharmacol 2003;55:109-112 (Pubitemid 36411126)
50. Zielonka J, Ge?bicki J, Grynkiewicz G. Radical scavenging properties of genistein. Free Radic BiolMed 2003;35:958-965 (Pubitemid 37211450)
51. Caron G, Steyaert G, Pagliara A, Reymond F, Crivori P, Gaillard P, Carrupt PA, Avdeef A, Comer J, Box KJ, Girault HH, Testa B. Structure- lipophilicity relationships of neutral and protonated b-blockers. Part I. Intra-and intermolecular effects in isotropic solvent systems. Helv Chim Acta 1999;82:1211-1221
52. Bobrowski K. Pulse radiolysis studies concerning the reactions of hydrogen abstraction from tetraalkylammonium cations. J Phys Chem 1980;84:3524-3529
53. Shida T. Electronic absorption spectra of radical ions. Amsterdam: Elsevier; 1988
54. Hayon E, Ibata T, Lichtin NN, Simic M. Electron and hydrogen atom attachment to aromatic carbonyl compounds in aqueous solution. Absorption spectra and dissociation constants of ketyl radicals. J Phys Chem 1972;76:2072-2078
55. Kramer JH, Weglicki WB. A hydroxylated analog of the betaadrenoceptor antagonist, carvedilol, affords exceptional anti-oxidant protection to postischemic rat hearts. Free Radic Biol Med 1996;21:813-825 (Pubitemid 26365277)
56. Armstrong RC, Swallow AJ. Pulse-and gamma-radiolysis of aqueous solutions of tryptophan. Radiat Res 1969;40:563-579
57. Iddon B, Philips GO, Robbins KE. Radiation chemistry of aqueous solutions of indole and its derivatives. J Chem Soc B 1971;1887-1892
58. Bent DV, Hayon E. Excited state chemistry of aromatic amino acids and related peptides. III. Tryptophan. J Am Chem Soc 1975;97:2612-2619
59. Evans RF, Ghiron CA, VolkertWA,Kuntz RR. Flash photolysis of N-acetyl-L-tryptophanamide, acid-base equilibrium of the radical transients. Chem Phys Lett 1976;42:43-45
60. Posener MI, Adams GE, Wardman P, Cundall RB. Mechanism of tryptophan oxidation by some inorganic radical-anions: A pulse radiolysis study. J Chem Soc Faraday Trans I 1976;72:2231-2239
61. Arouma OI. Peroxyl radical scavenging activity of the antihypertensive drug carvedilol. Toxicol in vitro 1996;10:625-629
62. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Bohm M, Anker SD, Thompson SG, Poole-Wilson PA. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-225 (Pubitemid 40222359)
63. Jacob S, Rett K, Henriksen EJ. Antihypertensive therapy and insulin sensitivity: Do we have to redefine the role of beta-blocking agents?AmJ Hypertens 1998;11:1258-1265
64. Poirier L, Cleroux J, Nadeau A, Lacourciere Y. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients. J Hypertens 2001;19: 1429-1435 (Pubitemid 32730460)
65. Wollert KC, Drexler H. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: Carvedilol as the sun and center of the beta-blocker world? Circulation 2002;106:2164-2166 (Pubitemid 35222205)
66. Kobayashi N, Mita S, Yoshida K, Honda T, Kobayashi T, Hara K, Nakano S, Tsubokou Y, Matsuoka H. Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 via NF-kappaB induced by oxidative stress. Hypertens 2003;42:1004-1013. (Pubitemid 37413745)